115 related articles for article (PubMed ID: 21301464)
1. Appropriate response to influenza A (H1N1) virus vaccination in patients with inflammatory bowel disease on maintenance immunomodulator and/or biological therapy.
Molnár T; Farkas K; Jankovics I; Melles M; Nagy F; Szepes Z; Wittmann T
Am J Gastroenterol; 2011 Feb; 106(2):370-2. PubMed ID: 21301464
[No Abstract] [Full Text] [Related]
2. H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy.
Rahier JF; Papay P; Salleron J; Sebastian S; Marzo M; Peyrin-Biroulet L; Garcia-Sanchez V; Fries W; van Asseldonk DP; Farkas K; de Boer NK; Sipponen T; Ellul P; Louis E; Peake ST; Kopylov U; Maul J; Makhoul B; Fiorino G; Yazdanpanah Y; Chaparro M;
Gut; 2011 Apr; 60(4):456-62. PubMed ID: 21270121
[TBL] [Abstract][Full Text] [Related]
3. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
Mamula P; Markowitz JE; Piccoli DA; Klimov A; Cohen L; Baldassano RN
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):851-6. PubMed ID: 17544875
[TBL] [Abstract][Full Text] [Related]
4. [The efficiency of influenza vaccines in patients with inflammatory bowel disease on immunosuppressive therapy].
Farkas K; Terhes G; Deák J; Bálint A; Nagy F; Szepes Z; Wittmann T; Molnár T
Orv Hetil; 2012 Nov; 153(47):1870-4. PubMed ID: 23160078
[TBL] [Abstract][Full Text] [Related]
5. [Inflammatory bowel diseases].
Felley C; Guyot J; Hess J; Mottet C; Delarive J; Michetti P
Rev Med Suisse; 2005 Jan; 1(3):218-20, 223-7. PubMed ID: 15770816
[TBL] [Abstract][Full Text] [Related]
6. Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series.
Rahier JF; Papay P; Salleron J; Sebastian S; Ellul P; Teich N; Fiorino G; Blaha B; Garcia-Sanchez V; Haas T; Van Gossum A; Abitbol V; Yazdanpanah Y; Chaparro MC
Aliment Pharmacol Ther; 2011 Feb; 33(4):499-500. PubMed ID: 21235603
[No Abstract] [Full Text] [Related]
7. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
[TBL] [Abstract][Full Text] [Related]
8. Introducing vaccine against H1N1 influenza virus in schools.
Enquselassie F
Ethiop Med J; 2010 Oct; 48(4):2p preceding 257. PubMed ID: 21280426
[No Abstract] [Full Text] [Related]
9. Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy.
Shahgholi E; Ehsani MA; Salamati P; Maysamie A; Sotoudeh K; Mokhtariazad T
Pediatr Blood Cancer; 2010 May; 54(5):716-20. PubMed ID: 20205258
[TBL] [Abstract][Full Text] [Related]
10. [New influenza. What you should know about vaccination (interview by Dr. Judith Neumaier)].
Haas W
MMW Fortschr Med; 2009 Aug; 151(34-35):12. PubMed ID: 19771780
[No Abstract] [Full Text] [Related]
11. A swine of a pandemic.
Griffiths PD
Rev Med Virol; 2009 Sep; 19(5):253-6. PubMed ID: 19714698
[No Abstract] [Full Text] [Related]
12. Influenza vaccines in patients with IBD: ready for primetime?
Kunisaki KM
Gut; 2011 Apr; 60(4):433-4. PubMed ID: 21270120
[No Abstract] [Full Text] [Related]
13. Influenza A/H1N1 in 2009: a pandemic in evolution.
Clark T; Stephenson I
Expert Rev Vaccines; 2009 Jul; 8(7):819-22. PubMed ID: 19538107
[No Abstract] [Full Text] [Related]
14. Efficacy of inactivated trivalent influenza vaccine in alleviating the febrile illness of culture-confirmed influenza in children in the 2000-2001 influenza season.
Kamada M; Nagai T; Kumagai T; Igarashi M; Ihara T; Okafuji T; Ochiai H; Sakiyama H; Shimomura K; Suzuki E; Torigoe S; Miyazaki C; Miyata A; Yuri K; Ito Y; Nakayama T; Kase T; Okuno Y
Vaccine; 2006 Apr; 24(17):3618-23. PubMed ID: 16530300
[TBL] [Abstract][Full Text] [Related]
15. Public health. Rethinking influenza.
Rappuoli R; Del Giudice G; Nabel GJ; Osterhaus AD; Robinson R; Salisbury D; Stöhr K; Treanor JJ
Science; 2009 Oct; 326(5949):50. PubMed ID: 19797644
[No Abstract] [Full Text] [Related]
16. The role of seasonal influenza vaccination in preventing pandemic 2009 influenza (H1N1) during a school outbreak.
Liu LJ; Zhang XA; Wei MT; He C; Zhang L; Yang H; Liu W; Cao WC; Xin DS; Zhao PY; He C; Zhang L
J Clin Virol; 2010 Nov; 49(3):225-6. PubMed ID: 20817546
[No Abstract] [Full Text] [Related]
17. How did the 2008-2009 seasonal influenza vaccine affect the pandemic?
Glezen WP
Clin Infect Dis; 2010 Dec; 51(12):1380-2. PubMed ID: 21067354
[No Abstract] [Full Text] [Related]
18. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.
Lu CC; Wang YC; Lai JH; Lee TS; Lin HT; Chang DM
Vaccine; 2011 Jan; 29(3):444-50. PubMed ID: 21078406
[TBL] [Abstract][Full Text] [Related]
19. AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.
Roman F; Vaman T; Kafeja F; Hanon E; Van Damme P
Clin Infect Dis; 2010 Sep; 51(6):668-77. PubMed ID: 20687838
[TBL] [Abstract][Full Text] [Related]
20. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
